Physician profile
James E Ip
NPI 1699709725
$346,776.76
in general payments reported to CMS, 2019-2025
18 companies · $81K in 2025
The $81K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $7,476 · 2021: $24K · 2022: $92K · 2023: $34K · 2024: $79K · 2025: $81K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $142K · Travel and Lodging: $33K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Food and Beverage: $6,370 · Entertainment: $99.12 · Honoraria: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $141,662.50 |
| Travel and Lodging | $33,201.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,625.00 |
| Food and Beverage | $6,369.52 |
| Entertainment | $99.12 |
| Honoraria | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $261,120.87 | 2019-2025 | Aveir, Accent, Tendril |
| Biotronik INC. | $20,331.46 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Medtronic, INC. | $20,246.27 | 2021-2025 | Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $19,837.22 | 2021-2025 | Emblem Mri S-Icd, Clinical Trial Product, Watchman Access System |
| Medtronic Vascular, INC. | $13,568.27 | 2019-2020 | |
| Edwards Lifesciences Corporation | $3,500.00 | 2019 | |
| Altathera Pharmaceuticals LLC | $3,418.35 | 2024 | Sotalol Hydrochloride |
| Ebr Systems, INC. | $2,499.15 | 2025 | |
| Philips North America LLC | $1,366.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $400.00 | 2019 | |
| Biosense Webster, INC. | $129.67 | 2019-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.13 | 2024 | Lifevest |
| Stereotaxis INC | $99.12 | 2024 | Genesis |
| Zoll Respicardia, INC. | $45.34 | 2025 | Remede System |
| Atricure, INC. | $36.78 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $31.23 | 2020 | |
| Impulse Dynamics (USA) INC. | $27.36 | 2023 | Optimizer |
| C. R. Bard, INC. & Subsidiaries | $20.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.